The Nobel Laureate Walks Toward the Drug Lab
Demis Hassabis told staff AGI is close, then stepped back from running Google DeepMind to focus on AI drug discovery at Isomorphic Labs. What that choice signals.
Demis Hassabis told staff AGI is close, then stepped back from running Google DeepMind to focus on AI drug discovery at Isomorphic Labs. What that choice signals.
Axios frames Google's slipped Gemini 3.5 Pro launch as a symptom of DeepMind frustration — and reveals what permanent shipping pressure does to a research lab.
Google's Gemini app reaching one billion users marks a cultural turning point where daily conversation with an AI has become a normalized part of human life.